Vaderis Therapeutics

News

A trial of Vaderis' AKT inhibitor engasertib finds it could be the first effective treatment for rare disease hereditary haemorrhagic telangiectasia.

News

In another setback for abortion care in the US, an appeals court has issued an order restricting the distribution of mifepristone through the mail.

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.